View of Neoadjuvant pembrolizumab with paclitaxel and carboplatin in locally advanced esophageal and esophagogastric junction carcinoma: short-term outcomes of a single-center retrospective cohort

Return to Article Details Neoadjuvant pembrolizumab with paclitaxel and carboplatin in locally advanced esophageal and esophagogastric junction carcinoma: short-term outcomes of a single-center retrospective cohort Download Download PDF